Table 4.
Clinical symptoms and adverse events following CQ–PQ treatment during the follow-up period
| Adverse events/clinical symptoms | Before treatment | After treatment | ||||
|---|---|---|---|---|---|---|
| Day 0 | Day 1 | Day 2 | Day 3 | Day 7 | Day 14 | |
| Abdominal pain, n (%) | 5 (5%) | 8 (8%) | 6 (6%) | 3 (3%) | 1 (1%) | – |
| Cough, n (%) | 6 (6%) | 5 (5%) | 3 (3%) | 1 (1%) | – | – |
| Diarrhea, n (%) | 2 (2%) | 5 (4%) | 2 (2%) | 1 (1%) | – | – |
| Dizziness, n (%) | 9 (9%) | 3 (3%) | – | – | – | – |
| Fever, n (%) | 90 (90%) | 9 (10%) | 2 (2%) | 1 (1%) | 1 (1%) | – |
| Joint/muscle pain, n (%) | 36 (36%) | 12 (12%) | – | – | – | – |
| Headache, n (%) | 86 (86%) | 7 (7%) | 1 (1%) | – | 1 (1%) | – |
| Nausea, n (%) | 27 (27%) | 12 (12%) | 3 (3%) | – | – | – |
| Vomiting, n (%) | 7 (7%) | 3 (3%) | – | – | – | – |